Inside BENEO’s new pulse plant: pioneering sustainable protein from faba beans
–Siddharth Shah, Founder, Essenzaa Nutrition
In Shaping Wellness Futures, the 10th feature of NUFFOODS Spectrum 12th Anniversary Special interview series, we spoke with Siddharth Shah, Founder of Essenzaa Nutrition. Shah shares how the company is charting its path to become a household health and wellness solution by 2030, blending innovation with traditional wisdom. From expanding its brands The Tiny Secret and Bree Matcha into high-growth segments to targeting a presence in 50+ countries, Essenzaa is investing in R&D, precision nutrition, and advanced delivery systems—setting the stage for a transparent, clean-label, and globally competitive nutraceutical future. Edited excerpts;
What are Essenzaa Nutrition’s strategic goals for 2030 regarding product portfolio, market reach, and brand positioning?
By the year 2030, we aim to become a household one stop solution for health and wellness through innovation and traditions.
Can you share upcoming innovations or product lines that will define your competitive edge over the next decade?
We are definitely looking to expand our portfolio and as a part of that exercise, our band, The Tiny Secret will venture deeper into the world of proteins and health supplements, while Bree Matcha will introduce flavoured Matcha’s and matcha pre mixes for our audiences.
What is your export growth target by 2030, and which regions are your top priorities?
Our growth target for the long run is spread across regions. To break it down further, we are gunning for a global presence in over 50 countries, with North America and MENA as our top priorities.
How are you investing in R&D, ingredient sourcing, and technology to meet future consumer and regulatory expectations?
Since our establishment, our core has been built on pillars of continuous research and traceability of the right ingredients. We aim to keep developing newer technologies and delivery formats for a new age consumer.
What role will new technologies—such as AI-driven formulation, precision nutrition, and advanced delivery systems—play in shaping the industry?
New technologies will be pivotal in redefining the botanical and herbal ingredients industry by 2030. AI-driven formulation will accelerate bioactive discovery, predict efficacy, and optimise ingredient synergies, cutting R&D timelines significantly. Precision nutrition, powered by omics and data analytics, will allow products to be tailored to individual health profiles, improving outcomes and consumer trust. Advanced delivery systems, including liposomal encapsulation, microencapsulation, and sustained-release formats, will enhance bioavailability and stability, ensuring maximum benefits.
Together, these innovations will create a smarter, more sustainable industry—one that delivers clinically validated, personalized, and effective solutions, while meeting global demand for transparency, clean-label products, and eco-conscious practices.
How can Indian nutraceutical companies position themselves as credible global suppliers in the next decade?
The best way for Indian nutraceutical companies to compete globally over the next decade is to prioritise uncompromising quality and clean-label formulations. This means adhering to stringent international standards, ensuring full traceability from farm to finished product, and eliminating unnecessary additives. By investing in R&D, clinical validation, and sustainable sourcing, companies can build trust with discerning global consumers. Transparent labeling, ethical practices, and consistent product efficacy will position India as not just a low-cost supplier, but a credible, innovation-driven leader in the global nutraceutical market.
What regulatory changes do you foresee by 2030, and how should the industry prepare to stay compliant and competitive?
By 2030, regulatory frameworks for nutraceuticals are expected to become more standardied, transparent, and strictly enforced worldwide. Execution by regulatory bodies will be more effective, with malpractices being identified and addressed swiftly. Stricter rules on product claims, labelling accuracy, ingredient traceability, and contaminant limits will demand higher accountability.
To stay compliant and competitive, companies must adopt a proactive approach—investing in robust quality systems, digital traceability, and third-party certifications. Continuous monitoring of evolving regulations, agile adaptation of processes, and transparent communication with stakeholders will ensure not only compliance but also a strong reputation in an increasingly demanding global marketplace.
Which long-term consumer trends—clean-label, plant-based, immunity-focused—will have the largest influence on industry growth by 2030?
By 2030, clean labels will become a non-negotiable standard as consumers grow increasingly aware and discerning about what goes into their products. Transparency in ingredient sourcing, processing methods, and certifications will drive purchasing decisions, with plant-based and naturally derived ingredients gaining strong preference.
Consumers will expect formulations free from artificial additives, allergens, and unnecessary fillers, while also demanding clear proof of safety and efficacy. This shift will push companies to adopt more stringent quality controls, invest in sustainable and ethical sourcing, and embrace science-backed claims. Clean labels will not just be a trend but a core driver of industry growth.
Mansi Jamsudkar Padvekar